Department of Neurology, Brigham and Women's Hospital, Boston, MA, USA.
Center for Neuro-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Neuro Oncol. 2023 Feb 14;25(2):234-247. doi: 10.1093/neuonc/noac211.
Genomic and transcriptional heterogeneity is prevalent among the most common and aggressive primary brain tumors in children and adults. Over the past 20 years, advances in bioengineering, biochemistry and bioinformatics have enabled the development of an array of techniques to study tumor biology at single-cell resolution. The application of these techniques to study primary brain tumors has helped advance our understanding of their intra-tumoral heterogeneity and uncover new insights regarding their co-option of developmental programs and signaling from their microenvironment to promote tumor proliferation and invasion. These insights are currently being harnessed to develop new therapeutic approaches. Here we provide an overview of current single-cell techniques and discuss relevant biology and therapeutic insights uncovered by their application to primary brain tumors in children and adults.
基因组和转录组异质性在儿童和成人中最常见和侵袭性的原发性脑肿瘤中普遍存在。在过去的 20 年中,生物工程、生物化学和生物信息学的进步使一系列技术得以发展,能够以单细胞分辨率研究肿瘤生物学。将这些技术应用于研究原发性脑肿瘤有助于我们加深对其肿瘤内异质性的理解,并揭示关于其对发育程序的选择以及来自微环境的信号的新见解,以促进肿瘤的增殖和侵袭。这些见解目前正被用于开发新的治疗方法。在这里,我们提供了当前单细胞技术的概述,并讨论了将其应用于儿童和成人原发性脑肿瘤中所揭示的相关生物学和治疗学见解。